B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis

Journal of Clinical Virology

Volumn 52, Issue 1, 2011, Pages 33-37

  Al Tabaa, Yassine ^a,b   Tuaillon, Edouard ^a,b,c   Jeziorski, Eric ^b   Ouedraogo, David Eric ^a,b,c   Bolloré, Karine ^a,b,c   Rubbo, Pierre Alain ^a,b,c   Foulongne, Vincent ^a,b,c   Rodière, Michel ^b   Vendrell, Jean Pierre ^a,b,c  

^a UNIV MONTPELLIER   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c UMR 1058 University of Montpellier   (France)

Author keywords

Acute infectious mononucleosis; B cell polyclonal activation; BZLF1; EBV B cell reservoir; EBV late viral antigen; Epstein Barr virus

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMEDIATE EARLY PROTEIN BZLF1; VIRUS DNA;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; DNA INTEGRATION; EPSTEIN BARR VIRUS; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFECTIOUS MONONUCLEOSIS; LIFE CYCLE; PLASMA CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SECRETORY CELL; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

ACUTE DISEASE; ALPHA-MACROGLOBULINS; ANTIGENS, VIRAL; B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 79961126963     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.05.023     Document Type: Article

References (19)

1. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968, 59:94-101.
2. Callan M.F.C., Steven N., Krausa P., Wilson J.D.K., Moss P.A.H., Gillespie G.M., et al. Large clonal expansion of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996, 2:906-911.
3. Williams H., Macsween K., McAulay K., Higgins C., Harrison N., Swerdlow A., et al. Analysis of immune activation and clinical events in acute infectious mononucleosis. J Infect Dis 2004, 190:63-71.
4. Callan M.F.C., Tan L., Annels N., Ogg G.S., Wilson J.D.K., Callaghan C.A.O., et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Eptein-Barr virus in vivo. J Exp Med 1998, 187:1395-1402.
5. Callan M.F.C., Fazou C., Yang H., Rostron T., Poon K., Hatton C., et al. CD8+ T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest 2000, 106:1251-1261.
6. Mayashita E.M., Yang B., Babcock G.J., Thorley-Lawson D.A. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 1997, 71:4882-4891.
7. Babcock G.J., Decker L.L., Volk M., Thorley-Lawson D.A. EBV persistence in memory-B cells in vivo. Immunity 1998, 9:395-404.
8. Laichalk L.L., Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005, 79:1296-1307.
9. Hochberg D., Middeldorp J.M., Catalina M., Sullivan J.L., Luzuriaga K., Thorley-Lawson D.A. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci USA 2004, 101:239-244.
10. Al Tabaa Y., Tuaillon E., Bolloré K., Foulongne V., Petitjean G., Seigneurin J.M., et al. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory-B cells. Blood 2009, 182:7155-7162.
11. Hochberg D., Souza T., Catalina M., Sullivan J.L., Luzuriaga K., Thorley-Lawson D.A. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory-B-cell compartment with resting, latently infected cells. J Virol 2004, 78:5194-5204.
12. Hadinoto V., Shapiro M., Greenough T.C., Sullivan J.L., Luzuriaga K., Thorley-Lawson D.A. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 2008, 111:1420-1427.
13. Vendrell J.P. Peripheral blood naive and memory-B cells. Measuring immunity: basic biology and clinical assessment 2004, 277-288. Elsevier Academic Press, London. M.T. Lotze, A.W. Thomson (Eds.).
14. Brengel-Pesce K., Morand P., Schmuck A., Bourgeat M.J., Buisson M., Barguès G., et al. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol 2002, 66:360-369.
15. Cohen J.I. Eptein-Barr virus infection. N Engl J Med 2000, 343:481-492.
16. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory-B polyclonal activation of human memory-B cells. Science 2002, 298:2199-2202.
17. Schwarzmann F., Prang N., Reichelt B., Haist S., Marschall M., Wolf H. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J Gen Virol 1994, 75:1999-2006.
18. Prang N.S., Wolf H., Schwarzmann F.M. Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1. J Virol 1995, 69:2644-2648.
19. Souza T.A., Stollar B.D., Sullivan J.L., Luzuriaga K., Thorley-Lawson D.A. Influence of EBV on the peripheral blood memory-B cell compartment. J Immunol 2007, 179:3153-3160.